Wednesday, September 23, 2026

EUR/CHF Is 2% Up In The Last 21 Sessions

EUR/CHF Is 2% Up In The Last 21 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 2.91% for the last 21 sessions. At 09:06 EST on Friday, 1 March, EUR/CHF (EURCHF) is $0.96.

EUR/CHF's yearly highs and lows, it's 6.279% up from its 52-week low and 3.992% down from its 52-week high.

Volatility

EUR/CHF's last week, last month's, and last quarter's current intraday variation average was a negative 0.01%, a positive 0.12%, and a positive 0.24%, respectively.

EUR/CHF's highest amplitude of average volatility was 0.12% (last week), 0.20% (last month), and 0.24% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUR/CHF's Forex is considered to be overbought (>=80).

News about

  • Eur/usd mixed on Wednesday but pointed downward. According to FXStreet on Wednesday, 28 February, "Daily candlesticks remain hamstrung on the 200-day Simple Moving Average (SMA) near 1.0830, and the EUR/USD continues to drift into median bids despite a bullish recovery from the last swing low into 1.0700. "
  • Eur/usd depreciates on risk-off sentiment ahead of eurozone, US data, trades around 1.0840. According to FXStreet on Wednesday, 28 February, "On the other hand, Kit Juckes, Chief Global FX Strategist at Société Générale, highlights the significance of whether the Federal Reserve or the European Central Bank cuts rates first or most aggressively in determining the direction of the EUR/USD pair this year."
  • According to FXStreet on Thursday, 29 February, "The Euro shows little to no reaction to the above report, with EUR/USD flatlining near 1.0835, at the press time."
  • Eur/usd price analysis: depreciates to near 1.0830 followed by 21-day EMA. According to FXStreet on Thursday, 29 February, "The EUR/USD pair could find the immediate support zone around the 21-day Exponential Moving Average (EMA) at 1.0818 followed by the psychological support of 1.0800 level.", "A break below this support zone could prompt the EUR/USD pair to target the further the major level of 1.750 with an aim to navigate the region around the psychological level of 1.0700 aligned with February's low at 1.0694 level."
  • Eur/usd analysis: beware of renewed selling - 28 February 2024. According to DailyForex on Wednesday, 28 February, "According to the performance on the daily chart attached, the price of the EUR/USD currency pair is in a neutral position, and the general upward trend will not be confirmed without moving towards the psychological resistance level of 1.1000 again. ", "On the other hand, over the same period of time, the EUR/USD pair will return to its broader downward path by moving towards the 1.0730 support level again. "

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Frontier AI Slowdown Call Splits Industry, Rattles Capex-Sensitive Markets
Anthropic's Dario Amodei publicly called for a coordinated global slowdown in frontier AI development, a stance Microsoft echoed with a 'humanist' AI code of conduct, but Nvidia and Meta's CEOs rejected any coordinated pause days later, exposing a widening rift between safety-focused and growth-focused AI leaders. The dispute landed amid growing financial scrutiny of AI infrastructure spending — a hyperscaler capex analysis, FTC warnings against antitrust waivers for AI firms, and an 8.6% single-day stock drop in GE Vernova tied directly to the slowdown remarks — signaling investors are newly nervous about whether the AI capex boom (including Alphabet's projected $701B revenue narrative) can be justified if the pace of development itself becomes contested.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,983
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,983 facts checked against source5,304 source documents archived
Query this data → isubstrate.com